nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—GRM5—telencephalic ventricle—malignant glioma	0.0635	0.15	CbGeAlD
Rufinamide—SCN8A—cerebellar cortex—malignant glioma	0.0614	0.145	CbGeAlD
Rufinamide—Status epilepticus—Temozolomide—malignant glioma	0.0275	0.0934	CcSEcCtD
Rufinamide—GRM5—brainstem—malignant glioma	0.0172	0.0405	CbGeAlD
Rufinamide—GRM5—telencephalon—malignant glioma	0.0152	0.0359	CbGeAlD
Rufinamide—GRM5—midbrain—malignant glioma	0.0109	0.0258	CbGeAlD
Rufinamide—GRM5—spinal cord—malignant glioma	0.0107	0.0252	CbGeAlD
Rufinamide—SCN8A—brainstem—malignant glioma	0.00966	0.0228	CbGeAlD
Rufinamide—GRM5—central nervous system—malignant glioma	0.00866	0.0204	CbGeAlD
Rufinamide—SCN8A—telencephalon—malignant glioma	0.00858	0.0202	CbGeAlD
Rufinamide—GRM5—cerebellum—malignant glioma	0.00847	0.02	CbGeAlD
Rufinamide—SCN11A—spinal cord—malignant glioma	0.00793	0.0187	CbGeAlD
Rufinamide—Disturbance in attention—Temozolomide—malignant glioma	0.00747	0.0254	CcSEcCtD
Rufinamide—SCN1A—brainstem—malignant glioma	0.00731	0.0172	CbGeAlD
Rufinamide—GRM5—brain—malignant glioma	0.00688	0.0162	CbGeAlD
Rufinamide—Gait disturbance—Carmustine—malignant glioma	0.00686	0.0233	CcSEcCtD
Rufinamide—Coordination abnormal—Carmustine—malignant glioma	0.00682	0.0232	CcSEcCtD
Rufinamide—SCN2A—brainstem—malignant glioma	0.00671	0.0158	CbGeAlD
Rufinamide—Gait disturbance—Temozolomide—malignant glioma	0.00663	0.0226	CcSEcCtD
Rufinamide—Coordination abnormal—Temozolomide—malignant glioma	0.00659	0.0224	CcSEcCtD
Rufinamide—SCN1A—telencephalon—malignant glioma	0.00648	0.0153	CbGeAlD
Rufinamide—Urinary incontinence—Carmustine—malignant glioma	0.00646	0.022	CcSEcCtD
Rufinamide—SCN11A—central nervous system—malignant glioma	0.00643	0.0152	CbGeAlD
Rufinamide—Urinary incontinence—Temozolomide—malignant glioma	0.00625	0.0213	CcSEcCtD
Rufinamide—SCN8A—spinal cord—malignant glioma	0.00601	0.0142	CbGeAlD
Rufinamide—SCN2A—telencephalon—malignant glioma	0.00595	0.014	CbGeAlD
Rufinamide—SCN10A—telencephalon—malignant glioma	0.00574	0.0135	CbGeAlD
Rufinamide—SCN9A—midbrain—malignant glioma	0.00541	0.0128	CbGeAlD
Rufinamide—SCN9A—spinal cord—malignant glioma	0.00528	0.0125	CbGeAlD
Rufinamide—SCN3A—telencephalon—malignant glioma	0.00523	0.0123	CbGeAlD
Rufinamide—SCN11A—brain—malignant glioma	0.00511	0.012	CbGeAlD
Rufinamide—SCN1A—medulla oblongata—malignant glioma	0.00509	0.012	CbGeAlD
Rufinamide—SCN8A—central nervous system—malignant glioma	0.00488	0.0115	CbGeAlD
Rufinamide—Diplopia—Carmustine—malignant glioma	0.00486	0.0165	CcSEcCtD
Rufinamide—SCN8A—cerebellum—malignant glioma	0.00476	0.0112	CbGeAlD
Rufinamide—Diplopia—Temozolomide—malignant glioma	0.0047	0.016	CcSEcCtD
Rufinamide—SCN2A—medulla oblongata—malignant glioma	0.00468	0.011	CbGeAlD
Rufinamide—SCN1A—midbrain—malignant glioma	0.00466	0.011	CbGeAlD
Rufinamide—Ataxia—Carmustine—malignant glioma	0.00457	0.0156	CcSEcCtD
Rufinamide—SCN1A—spinal cord—malignant glioma	0.00454	0.0107	CbGeAlD
Rufinamide—Ataxia—Temozolomide—malignant glioma	0.00442	0.015	CcSEcCtD
Rufinamide—SCN7A—brain—malignant glioma	0.00434	0.0102	CbGeAlD
Rufinamide—SCN2A—midbrain—malignant glioma	0.00427	0.0101	CbGeAlD
Rufinamide—Breast disorder—Temozolomide—malignant glioma	0.00424	0.0144	CcSEcCtD
Rufinamide—SCN2A—spinal cord—malignant glioma	0.00417	0.00983	CbGeAlD
Rufinamide—SCN3A—medulla oblongata—malignant glioma	0.00411	0.00969	CbGeAlD
Rufinamide—SCN10A—spinal cord—malignant glioma	0.00402	0.00948	CbGeAlD
Rufinamide—Neutropenia—Carmustine—malignant glioma	0.00393	0.0134	CcSEcCtD
Rufinamide—Bronchitis—Temozolomide—malignant glioma	0.0039	0.0133	CcSEcCtD
Rufinamide—SCN8A—brain—malignant glioma	0.00387	0.00913	CbGeAlD
Rufinamide—SCN4A—central nervous system—malignant glioma	0.00382	0.00901	CbGeAlD
Rufinamide—Neutropenia—Temozolomide—malignant glioma	0.0038	0.0129	CcSEcCtD
Rufinamide—Dysuria—Temozolomide—malignant glioma	0.0038	0.0129	CcSEcCtD
Rufinamide—Pneumonia—Carmustine—malignant glioma	0.00377	0.0128	CcSEcCtD
Rufinamide—SCN3A—midbrain—malignant glioma	0.00376	0.00886	CbGeAlD
Rufinamide—Pollakiuria—Temozolomide—malignant glioma	0.00375	0.0128	CcSEcCtD
Rufinamide—SCN1A—central nervous system—malignant glioma	0.00369	0.00869	CbGeAlD
Rufinamide—Weight decreased—Temozolomide—malignant glioma	0.00367	0.0125	CcSEcCtD
Rufinamide—SCN3A—spinal cord—malignant glioma	0.00366	0.00864	CbGeAlD
Rufinamide—Pneumonia—Temozolomide—malignant glioma	0.00364	0.0124	CcSEcCtD
Rufinamide—Infestation NOS—Temozolomide—malignant glioma	0.00362	0.0123	CcSEcCtD
Rufinamide—Infestation—Temozolomide—malignant glioma	0.00362	0.0123	CcSEcCtD
Rufinamide—SCN1A—cerebellum—malignant glioma	0.0036	0.00849	CbGeAlD
Rufinamide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00342	0.0116	CcSEcCtD
Rufinamide—CES1—central nervous system—malignant glioma	0.00341	0.00805	CbGeAlD
Rufinamide—SCN9A—brain—malignant glioma	0.0034	0.00802	CbGeAlD
Rufinamide—Sinusitis—Temozolomide—malignant glioma	0.0034	0.0116	CcSEcCtD
Rufinamide—SCN2A—central nervous system—malignant glioma	0.00338	0.00798	CbGeAlD
Rufinamide—SCN2A—cerebellum—malignant glioma	0.00331	0.0078	CbGeAlD
Rufinamide—SCN10A—central nervous system—malignant glioma	0.00326	0.00769	CbGeAlD
Rufinamide—Urinary tract disorder—Temozolomide—malignant glioma	0.00321	0.0109	CcSEcCtD
Rufinamide—Urethral disorder—Temozolomide—malignant glioma	0.00318	0.0108	CcSEcCtD
Rufinamide—Eye disorder—Carmustine—malignant glioma	0.00314	0.0107	CcSEcCtD
Rufinamide—Eye disorder—Temozolomide—malignant glioma	0.00304	0.0103	CcSEcCtD
Rufinamide—SCN4A—brain—malignant glioma	0.00303	0.00716	CbGeAlD
Rufinamide—Cardiac disorder—Temozolomide—malignant glioma	0.00302	0.0103	CcSEcCtD
Rufinamide—SCN3A—central nervous system—malignant glioma	0.00297	0.00701	CbGeAlD
Rufinamide—SCN5A—central nervous system—malignant glioma	0.00296	0.00699	CbGeAlD
Rufinamide—Mental disorder—Carmustine—malignant glioma	0.00295	0.01	CcSEcCtD
Rufinamide—Immune system disorder—Temozolomide—malignant glioma	0.00293	0.00999	CcSEcCtD
Rufinamide—Mediastinal disorder—Temozolomide—malignant glioma	0.00293	0.00997	CcSEcCtD
Rufinamide—Malnutrition—Carmustine—malignant glioma	0.00293	0.00996	CcSEcCtD
Rufinamide—SCN1A—brain—malignant glioma	0.00293	0.0069	CbGeAlD
Rufinamide—SCN3A—cerebellum—malignant glioma	0.00291	0.00685	CbGeAlD
Rufinamide—Mental disorder—Temozolomide—malignant glioma	0.00285	0.00969	CcSEcCtD
Rufinamide—Back pain—Carmustine—malignant glioma	0.00283	0.00963	CcSEcCtD
Rufinamide—Malnutrition—Temozolomide—malignant glioma	0.00283	0.00963	CcSEcCtD
Rufinamide—Vision blurred—Carmustine—malignant glioma	0.00276	0.00939	CcSEcCtD
Rufinamide—Tremor—Carmustine—malignant glioma	0.00274	0.00933	CcSEcCtD
Rufinamide—Back pain—Temozolomide—malignant glioma	0.00274	0.00931	CcSEcCtD
Rufinamide—CES1—brain—malignant glioma	0.00271	0.00639	CbGeAlD
Rufinamide—Anaemia—Carmustine—malignant glioma	0.00271	0.00921	CcSEcCtD
Rufinamide—Agitation—Carmustine—malignant glioma	0.00269	0.00915	CcSEcCtD
Rufinamide—SCN2A—brain—malignant glioma	0.00269	0.00633	CbGeAlD
Rufinamide—Vision blurred—Temozolomide—malignant glioma	0.00267	0.00907	CcSEcCtD
Rufinamide—Tremor—Temozolomide—malignant glioma	0.00265	0.00902	CcSEcCtD
Rufinamide—Leukopenia—Carmustine—malignant glioma	0.00262	0.00892	CcSEcCtD
Rufinamide—Anaemia—Temozolomide—malignant glioma	0.00261	0.0089	CcSEcCtD
Rufinamide—Agitation—Temozolomide—malignant glioma	0.0026	0.00885	CcSEcCtD
Rufinamide—SCN10A—brain—malignant glioma	0.00259	0.00611	CbGeAlD
Rufinamide—Vertigo—Temozolomide—malignant glioma	0.00254	0.00865	CcSEcCtD
Rufinamide—Convulsion—Carmustine—malignant glioma	0.00254	0.00863	CcSEcCtD
Rufinamide—Leukopenia—Temozolomide—malignant glioma	0.00253	0.00862	CcSEcCtD
Rufinamide—Anxiety—Carmustine—malignant glioma	0.00248	0.00845	CcSEcCtD
Rufinamide—CYP2E1—telencephalon—malignant glioma	0.00247	0.00582	CbGeAlD
Rufinamide—Convulsion—Temozolomide—malignant glioma	0.00245	0.00834	CcSEcCtD
Rufinamide—Anxiety—Temozolomide—malignant glioma	0.0024	0.00817	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00239	0.00814	CcSEcCtD
Rufinamide—Infection—Carmustine—malignant glioma	0.00237	0.00808	CcSEcCtD
Rufinamide—SCN3A—brain—malignant glioma	0.00236	0.00557	CbGeAlD
Rufinamide—SCN5A—brain—malignant glioma	0.00235	0.00555	CbGeAlD
Rufinamide—Thrombocytopenia—Carmustine—malignant glioma	0.00234	0.00796	CcSEcCtD
Rufinamide—Infection—Temozolomide—malignant glioma	0.00229	0.0078	CcSEcCtD
Rufinamide—Anorexia—Carmustine—malignant glioma	0.00228	0.00775	CcSEcCtD
Rufinamide—Nervous system disorder—Temozolomide—malignant glioma	0.00226	0.0077	CcSEcCtD
Rufinamide—Thrombocytopenia—Temozolomide—malignant glioma	0.00226	0.00769	CcSEcCtD
Rufinamide—Skin disorder—Temozolomide—malignant glioma	0.00224	0.00763	CcSEcCtD
Rufinamide—Anorexia—Temozolomide—malignant glioma	0.0022	0.00749	CcSEcCtD
Rufinamide—Insomnia—Carmustine—malignant glioma	0.00216	0.00735	CcSEcCtD
Rufinamide—Somnolence—Carmustine—malignant glioma	0.00212	0.00723	CcSEcCtD
Rufinamide—Insomnia—Temozolomide—malignant glioma	0.00209	0.0071	CcSEcCtD
Rufinamide—Decreased appetite—Carmustine—malignant glioma	0.00208	0.00707	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00206	0.00702	CcSEcCtD
Rufinamide—Somnolence—Temozolomide—malignant glioma	0.00205	0.00698	CcSEcCtD
Rufinamide—Constipation—Carmustine—malignant glioma	0.00204	0.00695	CcSEcCtD
Rufinamide—Dyspepsia—Temozolomide—malignant glioma	0.00203	0.00691	CcSEcCtD
Rufinamide—Decreased appetite—Temozolomide—malignant glioma	0.00201	0.00683	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00199	0.00678	CcSEcCtD
Rufinamide—Fatigue—Temozolomide—malignant glioma	0.00199	0.00677	CcSEcCtD
Rufinamide—Constipation—Temozolomide—malignant glioma	0.00197	0.00672	CcSEcCtD
Rufinamide—CYP2E1—medulla oblongata—malignant glioma	0.00194	0.00458	CbGeAlD
Rufinamide—ALB—brain—malignant glioma	0.00188	0.00444	CbGeAlD
Rufinamide—Hypersensitivity—Carmustine—malignant glioma	0.00176	0.00599	CcSEcCtD
Rufinamide—CYP2E1—spinal cord—malignant glioma	0.00173	0.00408	CbGeAlD
Rufinamide—Asthenia—Carmustine—malignant glioma	0.00171	0.00583	CcSEcCtD
Rufinamide—Hypersensitivity—Temozolomide—malignant glioma	0.0017	0.00579	CcSEcCtD
Rufinamide—Asthenia—Temozolomide—malignant glioma	0.00166	0.00564	CcSEcCtD
Rufinamide—Diarrhoea—Carmustine—malignant glioma	0.00163	0.00556	CcSEcCtD
Rufinamide—Pruritus—Temozolomide—malignant glioma	0.00163	0.00556	CcSEcCtD
Rufinamide—Dizziness—Carmustine—malignant glioma	0.00158	0.00538	CcSEcCtD
Rufinamide—Diarrhoea—Temozolomide—malignant glioma	0.00158	0.00537	CcSEcCtD
Rufinamide—Dizziness—Temozolomide—malignant glioma	0.00153	0.00519	CcSEcCtD
Rufinamide—Vomiting—Carmustine—malignant glioma	0.00152	0.00517	CcSEcCtD
Rufinamide—Rash—Carmustine—malignant glioma	0.00151	0.00513	CcSEcCtD
Rufinamide—Dermatitis—Carmustine—malignant glioma	0.0015	0.00512	CcSEcCtD
Rufinamide—Headache—Carmustine—malignant glioma	0.0015	0.00509	CcSEcCtD
Rufinamide—Vomiting—Temozolomide—malignant glioma	0.00147	0.00499	CcSEcCtD
Rufinamide—Rash—Temozolomide—malignant glioma	0.00146	0.00495	CcSEcCtD
Rufinamide—Dermatitis—Temozolomide—malignant glioma	0.00145	0.00495	CcSEcCtD
Rufinamide—Headache—Temozolomide—malignant glioma	0.00145	0.00492	CcSEcCtD
Rufinamide—Nausea—Carmustine—malignant glioma	0.00142	0.00483	CcSEcCtD
Rufinamide—CYP2E1—central nervous system—malignant glioma	0.0014	0.00331	CbGeAlD
Rufinamide—CYP2E1—cerebellum—malignant glioma	0.00137	0.00324	CbGeAlD
Rufinamide—Nausea—Temozolomide—malignant glioma	0.00137	0.00467	CcSEcCtD
Rufinamide—CYP3A4—central nervous system—malignant glioma	0.00113	0.00266	CbGeAlD
Rufinamide—CYP2E1—brain—malignant glioma	0.00111	0.00263	CbGeAlD
Rufinamide—SCN5A—Developmental Biology—MET—malignant glioma	0.000171	0.000607	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000171	0.000605	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PDGFB—malignant glioma	0.00017	0.000602	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—malignant glioma	0.000169	0.000601	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—malignant glioma	0.000169	0.000601	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGFR1—malignant glioma	0.000169	0.000599	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HIF1A—malignant glioma	0.000166	0.000589	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.000165	0.000585	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—malignant glioma	0.000165	0.000585	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—malignant glioma	0.000164	0.000582	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—malignant glioma	0.000163	0.000579	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—malignant glioma	0.000163	0.000579	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—malignant glioma	0.000163	0.000577	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000161	0.000572	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CAV1—malignant glioma	0.000161	0.00057	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000161	0.000569	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.00016	0.000566	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KDR—malignant glioma	0.000159	0.000564	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.000158	0.000562	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—malignant glioma	0.000158	0.000562	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—malignant glioma	0.000158	0.000562	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000156	0.000553	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—malignant glioma	0.000156	0.000553	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000156	0.000552	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—malignant glioma	0.000155	0.000549	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—STAT3—malignant glioma	0.000153	0.000543	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—F2—malignant glioma	0.000153	0.000543	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FN1—malignant glioma	0.000153	0.000543	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—malignant glioma	0.000153	0.000542	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—malignant glioma	0.000153	0.000542	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000152	0.000537	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000151	0.000536	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BAD—malignant glioma	0.000151	0.000536	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—malignant glioma	0.000151	0.000534	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MYB—malignant glioma	0.00015	0.000532	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—malignant glioma	0.00015	0.000531	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOTCH1—malignant glioma	0.00015	0.000531	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00015	0.000531	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000149	0.000527	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—malignant glioma	0.000148	0.000525	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT2—malignant glioma	0.000148	0.000523	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CD80—malignant glioma	0.000147	0.00052	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—STAT3—malignant glioma	0.000147	0.00052	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CG—malignant glioma	0.000147	0.000519	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APC—malignant glioma	0.000147	0.000519	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000145	0.000514	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGF—malignant glioma	0.000145	0.000513	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTPN11—malignant glioma	0.000144	0.00051	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000143	0.000507	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—malignant glioma	0.000142	0.000504	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—malignant glioma	0.000142	0.000504	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—STAT3—malignant glioma	0.000141	0.000499	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—STAT3—malignant glioma	0.000141	0.000499	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COX8A—malignant glioma	0.00014	0.000497	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—malignant glioma	0.000139	0.000494	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BRAF—malignant glioma	0.000138	0.000488	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—malignant glioma	0.000138	0.000488	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—malignant glioma	0.000137	0.000486	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—malignant glioma	0.000137	0.000486	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—STAT3—malignant glioma	0.000136	0.000482	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—STAT3—malignant glioma	0.000136	0.000482	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000136	0.000481	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000135	0.000479	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000134	0.000475	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT2—malignant glioma	0.000134	0.000475	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—malignant glioma	0.000134	0.000473	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—malignant glioma	0.000133	0.000473	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—malignant glioma	0.000133	0.000472	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—malignant glioma	0.000133	0.00047	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—malignant glioma	0.000132	0.000467	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CD—malignant glioma	0.000129	0.000457	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—malignant glioma	0.000128	0.000454	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—malignant glioma	0.000128	0.000454	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CA—malignant glioma	0.000128	0.000452	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—malignant glioma	0.000127	0.00045	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—RAF1—malignant glioma	0.000127	0.000449	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—malignant glioma	0.000126	0.000447	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—malignant glioma	0.000126	0.000446	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—malignant glioma	0.000125	0.000444	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000124	0.000439	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—malignant glioma	0.000123	0.000438	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—malignant glioma	0.000123	0.000438	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGF2—malignant glioma	0.000123	0.000437	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—malignant glioma	0.000122	0.000433	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—malignant glioma	0.000122	0.000432	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—malignant glioma	0.000122	0.000432	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—malignant glioma	0.000122	0.000431	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000121	0.000429	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000121	0.000429	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—malignant glioma	0.000121	0.000429	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—malignant glioma	0.000121	0.000429	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COX8A—malignant glioma	0.00012	0.000427	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ASMT—malignant glioma	0.000119	0.000422	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—malignant glioma	0.000118	0.000417	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—malignant glioma	0.000118	0.000417	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—H3F3A—malignant glioma	0.000117	0.000415	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—malignant glioma	0.000117	0.000413	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—malignant glioma	0.000117	0.000413	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—malignant glioma	0.000116	0.000411	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000116	0.00041	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MDM2—malignant glioma	0.000115	0.000409	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RAF1—malignant glioma	0.000115	0.000408	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—malignant glioma	0.000115	0.000407	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000114	0.000406	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—malignant glioma	0.000114	0.000403	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000113	0.000401	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CB—malignant glioma	0.000112	0.000398	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCAN—malignant glioma	0.000112	0.000397	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000112	0.000397	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00011	0.000391	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—malignant glioma	0.000108	0.000382	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000108	0.000381	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—malignant glioma	0.000107	0.000381	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000106	0.000375	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—malignant glioma	0.000104	0.000369	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—malignant glioma	0.000103	0.000366	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—malignant glioma	0.000103	0.000365	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ASMT—malignant glioma	0.000102	0.000363	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000102	0.000363	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000102	0.000361	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.0001	0.000355	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—malignant glioma	9.88e-05	0.00035	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—malignant glioma	9.76e-05	0.000346	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—malignant glioma	9.7e-05	0.000344	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KNG1—malignant glioma	9.65e-05	0.000342	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—malignant glioma	9.64e-05	0.000342	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCAN—malignant glioma	9.63e-05	0.000341	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—malignant glioma	9.55e-05	0.000339	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—malignant glioma	9.46e-05	0.000335	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—malignant glioma	9.45e-05	0.000335	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—malignant glioma	9.45e-05	0.000335	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.4e-05	0.000333	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	9.09e-05	0.000322	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—malignant glioma	9.08e-05	0.000322	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—malignant glioma	9.08e-05	0.000322	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH2—malignant glioma	9.03e-05	0.00032	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SOD1—malignant glioma	8.96e-05	0.000318	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.94e-05	0.000317	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	8.87e-05	0.000314	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—malignant glioma	8.76e-05	0.000311	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—malignant glioma	8.75e-05	0.00031	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—malignant glioma	8.75e-05	0.00031	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—malignant glioma	8.68e-05	0.000308	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—malignant glioma	8.68e-05	0.000308	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2B6—malignant glioma	8.49e-05	0.000301	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—malignant glioma	8.27e-05	0.000293	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PTK2—malignant glioma	8.23e-05	0.000292	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—malignant glioma	8.2e-05	0.000291	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	8.15e-05	0.000289	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—malignant glioma	8.06e-05	0.000286	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—malignant glioma	7.89e-05	0.00028	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH1—malignant glioma	7.76e-05	0.000275	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH2—malignant glioma	7.76e-05	0.000275	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SPHK1—malignant glioma	7.51e-05	0.000266	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—malignant glioma	7.45e-05	0.000264	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2C18—malignant glioma	7.36e-05	0.000261	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.32e-05	0.000259	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2B6—malignant glioma	7.29e-05	0.000259	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	6.92e-05	0.000245	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PDGFB—malignant glioma	6.91e-05	0.000245	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—malignant glioma	6.84e-05	0.000243	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH1—malignant glioma	6.67e-05	0.000236	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—malignant glioma	6.62e-05	0.000235	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—malignant glioma	6.55e-05	0.000232	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COX8A—malignant glioma	6.5e-05	0.00023	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SPHK1—malignant glioma	6.46e-05	0.000229	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2C18—malignant glioma	6.32e-05	0.000224	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—F2—malignant glioma	6.24e-05	0.000221	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FN1—malignant glioma	6.24e-05	0.000221	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—malignant glioma	6.15e-05	0.000218	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—malignant glioma	5.97e-05	0.000212	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.96e-05	0.000211	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—malignant glioma	5.95e-05	0.000211	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—malignant glioma	5.9e-05	0.000209	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PTPN11—malignant glioma	5.86e-05	0.000208	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—malignant glioma	5.59e-05	0.000198	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS1—malignant glioma	5.58e-05	0.000198	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ASMT—malignant glioma	5.53e-05	0.000196	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT2—malignant glioma	5.46e-05	0.000194	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.43e-05	0.000193	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	5.41e-05	0.000192	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—malignant glioma	5.25e-05	0.000186	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.24e-05	0.000186	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCAN—malignant glioma	5.2e-05	0.000184	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCHE—malignant glioma	5.18e-05	0.000184	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—malignant glioma	5.12e-05	0.000182	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—malignant glioma	5.12e-05	0.000181	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS1—malignant glioma	4.79e-05	0.00017	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.78e-05	0.000169	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAF1—malignant glioma	4.68e-05	0.000166	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—malignant glioma	4.57e-05	0.000162	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCHE—malignant glioma	4.46e-05	0.000158	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.42e-05	0.000157	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—malignant glioma	4.4e-05	0.000156	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—malignant glioma	4.2e-05	0.000149	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH2—malignant glioma	4.19e-05	0.000148	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.16e-05	0.000148	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—malignant glioma	4.13e-05	0.000146	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.12e-05	0.000146	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.05e-05	0.000144	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAT—malignant glioma	4.01e-05	0.000142	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.94e-05	0.00014	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR1—malignant glioma	3.79e-05	0.000134	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH1—malignant glioma	3.6e-05	0.000128	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.6e-05	0.000127	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—malignant glioma	3.57e-05	0.000126	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—malignant glioma	3.55e-05	0.000126	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SPHK1—malignant glioma	3.48e-05	0.000124	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAT—malignant glioma	3.45e-05	0.000122	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.41e-05	0.000121	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR1—malignant glioma	3.26e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—malignant glioma	3.09e-05	0.00011	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—malignant glioma	3.03e-05	0.000108	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—malignant glioma	2.81e-05	9.98e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—malignant glioma	2.79e-05	9.88e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—malignant glioma	2.76e-05	9.79e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—malignant glioma	2.72e-05	9.63e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—malignant glioma	2.7e-05	9.56e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—malignant glioma	2.66e-05	9.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS1—malignant glioma	2.59e-05	9.17e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.54e-05	8.99e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—malignant glioma	2.47e-05	8.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—malignant glioma	2.42e-05	8.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCHE—malignant glioma	2.41e-05	8.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.38e-05	8.42e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—malignant glioma	2.33e-05	8.28e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—malignant glioma	2.28e-05	8.07e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—malignant glioma	2.16e-05	7.65e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—malignant glioma	2.14e-05	7.58e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—malignant glioma	2.13e-05	7.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.91e-05	6.78e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—malignant glioma	1.86e-05	6.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAT—malignant glioma	1.86e-05	6.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—malignant glioma	1.85e-05	6.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—malignant glioma	1.84e-05	6.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR1—malignant glioma	1.76e-05	6.23e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—malignant glioma	1.6e-05	5.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—malignant glioma	1.43e-05	5.08e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.31e-05	4.66e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.31e-05	4.63e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—malignant glioma	1.26e-05	4.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.15e-05	4.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—malignant glioma	1.13e-05	4.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—malignant glioma	1.07e-05	3.81e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	1e-05	3.55e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—malignant glioma	9.92e-06	3.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—malignant glioma	9.23e-06	3.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—malignant glioma	8.65e-06	3.07e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.1e-06	2.16e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—malignant glioma	4.98e-06	1.77e-05	CbGpPWpGaD
